Sometimes, US-based small startups find their evolving R&D plan, funding, or business collaborations make them suddenly ineligible for SBIR funding they had targeted. For example, clinical trial costs or even lab work would be cheaper overseas, so, just like that, eligibility slips away.
What to do? Continue reading “The EU’s World-Class R&D Funding and Support for Innovators”
Strategic Grantsmanship 